X

Drug Profile

West Nile virus vaccine - Crucell

Alternative Names: PER.C6 cell line-based West Nile virus vaccine - Crucell; Whole-killed West Nile Virus Vaccine - Crucell

Latest Information Update: 06 Mar 2008

Price :

$50 ^*

Note:

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Crucell
Class Viral vaccines
Mechanism of Action Immunostimulants

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Discontinued West Nile virus infections

Most Recent Events

12 Feb 2008 Discontinued - Phase-I for West Nile virus infections prevention in Belgium (IM)
02 Feb 2007 Clinical data added to the adverse events section
13 Jun 2003 Preclinical trials in West Nile virus infections in Netherlands (unspecified route)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com